A medical marijuana expansion bill passed the state Assembly Thursday by a wide margin, with only a few legislators expressing concerns. Named the “Jake Honig Compassionate Use Medical Cannabis Act” in honor of 7-year-old Jake Honig from Howell who used medical marijuana when fighting terminal brain cancer, the measure passed 65-5 vote, with six legislators abstaining.
If passed by the Senate — possibly next week — and signed by the governor, the new law would increase the number of medical permits for cannabis operations in New Jersey from 12 to 23; regulate the cultivation and sale of medical marijuana including edibles; develop a new category of designated caregiver for senior patients and those who need extra assistance obtaining or consuming cannabis, and establish a Cannabis Regulatory Commission to oversee the implementation of medical cannabis in the state.
When Democrats’ hopes of legalizing recreational use of cannabis via legislation, plan B was a — sort of a “backdoor” to adult-use legalization as Senate President Steve Sweeney said in an interview with NJ Spotlight on Wednesday.
“This critical legislation, which would dramatically expand access to medicinal cannabis, is a potential victory for all New Jersey patients and families for whom medical marijuana would provide essential treatment, therapy and pain relief,” Assemblywoman and prime bill sponsor Joann Downey (D-Monmouth) said on the floor of the Assembly yesterday.
One legislator who voted “no,” John DiMaio (R-Morris) said he opposed the imposition of the state sales tax on the medicine. The bill would eliminate the tax in 2025 but DiMaio said that wasn’t good enough and requested the bill go back to committee for amendments.
“I don't think it's fair that [for] people who are sick and suffering that we should be in their pockets for money,” he said.
Almostor symptoms currently are eligible for medical marijuana including opioid use disorders, ALS, and chronic pain and the program covers 46,300 patients, according to state data.
An accompanying expungement bill to clear the records of those with prior marijuana arrests will likely come before the Assembly after the Senate votes on it, potentially on May 30. A Senate voting session scheduled for Thursday, at which expungement and decriminalization measures were expected to be heard, was canceled. Neither of those bills was up for a vote in the Assembly.
The medical marijuana bill passed by the Assembly/S-10)] would nearly double the number of permits available for medical marijuana operations to 23; it would also increase the amount of medical marijuana that patients are allowed to buy from two ounces to three ounces each month.
In addition, it would break up the permitting system, allowing businesses to serve one purpose (either retail sales, growing, or manufacturing, for example, as opposed to current law which requires businesses to be vertically integrated and do it all — grow, package, process and sell). The bill would also put a cap on the number of grower permits at 23 for the first 18 months (including the existing 12 medical marijuana dispensary licenses).
The measure would also remove a major barrier for many potential patients. Current law requires a “bona fide relationship” between doctors and patients before the practitioner can make a formal recommendation for cannabis medical treatment. In practice, this means patients must have one year or more of regular appointments under their belt with the same doctor. The new bill would remove that requirement and allow doctors to recommend cannabis as they would any other medication. What’s more, not only doctors would be able to recommend the treatment. Physician assistants and some advanced-practice nurses would also be certified to recommend cannabis for patients.
The new law would also allow those who may be physically unable to travel to a dispensary to pick up their cannabis medicine to designate two registered caregivers to collect it on their behalf. Current law restricts patients to one caregiver.
The medical expansion bill had been tied to the adult-use legalization plan for months as Democratic leaders hoped linking the issues would earn the recreational-use bill more votes. Now that the legislative route for legalization of recreational use has died and the issue will instead be put to voters through a 2020 ballot question, many aspects of the recreational bill have been incorporated into the medical expansion plan including:
A five-member Cannabis Regulatory Commission in, but not of, the Department of the Treasury which would assume all powers of oversight and regulation that previously had been under the Department of Health’s jurisdiction. That commission was a major negotiation point in the legalization talks and has been brought over to the medical side;
The inclusion on the commission of at least one “social justice” member representative of a national organization with a “stated mission of studying, advocating, or adjudicating against minority historical oppression, past and present discrimination, unemployment, poverty and income inequality, and other forms of social injustice or inequality”;
Provisions for small minority- and women-owned businesses. The bill notes 30 percent of new licenses would be issued to veterans, women and minorities. Fifteen percent of licenses would go to minority owners and the other 15 percent to the disabled, veterans, and women;
Deliveries would also be allowed. The bill notes “a medical cannabis dispensary may furnish medical cannabis, medical cannabis products, paraphernalia, and related supplies to a medical cannabis handler for delivery to a registered qualifying patient, designated caregiver, or institutional caregiver”;
Municipalities would be able to enact ordinances to create consumption areas where people could use their medicine;
Medical marijuana cards licensed in other states would also work in New Jersey. The bill says that “an individual who is registered as a qualifying patient in another state or jurisdiction within the United States that authorizes the medical use of cannabis shall be considered a registered qualifying patient for the purposes for a period of up to six months.”
Regarding taxation — DiMaio’s concern — the bill would impose the state’s 6.625 percent sales tax on medicinal cannabis purchases, with that money to go to programs for the treatment of mental health and substance use disorders. Localities with a dispensary within their borders would also be able to levy a 2 percent transfer tax in addition.
Assemblyman Joe Danielsen (D-Somerset) agreed with DiMaio that taxing medicine is not preferred. However, he noted that the state will not be able to rely on the federal Food and Drug Administration to assist with oversight or regulation of cannabis.
“It is sad that we are taxing but remember this, we do not have an FDA to help us out, we have to be our own FDA, our own regulatory agency, and that costs money,” Danielsen said.